Ganot Capital
Overview
Ganot Capital is a family-owned private equity firm specializing in healthcare and life sciences investments. The firm focuses on acquiring and investing in senior care, real estate, healthcare services, medical devices, and biopharmaceutical sectors through buyouts, growth capital, and venture capital strategies. Established in 2009, Ganot Capital leverages over five decades of experience in healthcare investments. The firm's investment approach is characterized by a hands-on management style, aiming to enhance the value of its portfolio companies through strategic guidance and operational improvements. Ganot Capital's portfolio includes companies such as Notal Vision, a diagnostic services company focused on enhancing the management of eye diseases, and Azura Ophthalmics, a clinical-stage company developing innovative treatments for Meibomian Gland Dysfunction. These investments reflect the firm's commitment to advancing medical technologies and improving patient outcomes.
Investment Focus
- Innovative therapies
- Medical technologies
- High growth potential
Portfolio Companies
Reach Ganot Capital directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Ganot Capital
What sectors does Ganot Capital invest in?
Ganot Capital invests in Healthcare, Real Estate, Life Sciences, Medical Devices and Biopharmaceuticals, and is based in Israel. Ganot Capital is listed as a private equity in the ConnectSafely investor database.
What stage does Ganot Capital invest at?
Ganot Capital backs companies at Buyout.
Which regions does Ganot Capital invest in?
Ganot Capital invests across United States, Europe, Asia and Israel.
What companies has Ganot Capital invested in?
Ganot Capital's portfolio includes Notal Vision and Azura Ophthalmics.
Last updated · Source: ConnectSafely investor database
